GR880100338A - Method of potentialization of homeopathic remedies - Google Patents

Method of potentialization of homeopathic remedies

Info

Publication number
GR880100338A
GR880100338A GR88100338A GR880100338A GR880100338A GR 880100338 A GR880100338 A GR 880100338A GR 88100338 A GR88100338 A GR 88100338A GR 880100338 A GR880100338 A GR 880100338A GR 880100338 A GR880100338 A GR 880100338A
Authority
GR
Greece
Prior art keywords
small
clathrates
impact
solvent
clusters
Prior art date
Application number
GR88100338A
Other languages
Greek (el)
Other versions
GR1000213B (en
Inventor
Gerasimos Anagnostatos
Konstantina Tavouxoglou
Georgios Vuthoulkas
Petros Garzonis
Original Assignee
Anagnostatos
Tavouxoglou
Vuthoulkas
Garzonis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anagnostatos, Tavouxoglou, Vuthoulkas, Garzonis filed Critical Anagnostatos
Publication of GR880100338A publication Critical patent/GR880100338A/en
Publication of GR1000213B publication Critical patent/GR1000213B/en

Links

Abstract

This abstract concerns a method of strengthening homeopathic drugs and aims at the manufacturing of better drugs using a standardized form of production and with stable replicable properties. The method utilizes for the very first time recent knowledge in physics and chemistry with regard to small clusters and clathrates. Specifically, it is considered that the initial solutions for the production of a drug must contain small aggregates of the dissolved pharmaceutical substance (clusters). These small clusters create reclassifications of the solvent's molecules that surround them, with the final result being the creation of shells from the solvent's molecules that are combined through hydrogen bonds (clathrates) and that have a symmetrical and durable shape similar to the shape of the small clusters (See Diagram 1). During the impact that accompanies the production of the drug the small clusters separate from the clathrates and in turn a new clathrate is formed around the small cluster in its new position and around the initial cluster that has now shrunk after the separation of the small cluster (Diagram 2). In advanced solutions where essentially there are no longer any traces of the initial substance, the activation of the solvent continues as shown in Diagram 3, where the role of the small cluster of Diagram 2 is played by the solid interior clathrate. The value of this invention lies in the differences between it and other existing methods. The prerequisite of the small clusters and the creation of clathrates is exclusive to this invention. The correlation of the strength of impact with properties of the solvent and the dissolved substance, the restriction of impact in a set direction, the frequency of impact, the number of impacts per dissolution in relation to the dimensions of the container, the time between two consecutive dissolutions and the importance of the number of dissolutions to the properties of the drug are characteristic features of the method and those which we want to safeguard.
GR880100338A 1988-05-23 1988-05-23 Method of potentialization of homeopathic remedies GR1000213B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR88100338 1988-05-23

Publications (2)

Publication Number Publication Date
GR880100338A true GR880100338A (en) 1990-03-12
GR1000213B GR1000213B (en) 1992-04-17

Family

ID=10938745

Family Applications (1)

Application Number Title Priority Date Filing Date
GR880100338A GR1000213B (en) 1988-05-23 1988-05-23 Method of potentialization of homeopathic remedies

Country Status (1)

Country Link
GR (1) GR1000213B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0165551A2 (en) * 1984-06-19 1985-12-27 BEHRINGWERKE Aktiengesellschaft Process for the determination of a reaction partner and apparatus therefor
FR2589239A1 (en) * 1985-10-24 1987-04-30 Cottingham Hugh Agglutinographic reaction chamber

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0165551A2 (en) * 1984-06-19 1985-12-27 BEHRINGWERKE Aktiengesellschaft Process for the determination of a reaction partner and apparatus therefor
FR2589239A1 (en) * 1985-10-24 1987-04-30 Cottingham Hugh Agglutinographic reaction chamber

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CLAIMS SEARCHED: ALL *

Also Published As

Publication number Publication date
GR1000213B (en) 1992-04-17

Similar Documents

Publication Publication Date Title
HUP0004050A2 (en) Itraconazole exhibiting improved solubility, a method of preparing the same and pharmaceutical composition for oral administration comprising the same
SE9501384D0 (en) Process for the preparation of respirable particles
BG104317A (en) Method for the treatment of capsules and dry, powder pharmaceutical forms
CA2346350A1 (en) Intraoral quickly disintegrating tablets
ATE196422T1 (en) RAPID DISSOLVING PHARMACEUTICAL DOSAGE FORMS AND METHOD FOR THEIR PRODUCTION
HUT38263A (en) Process for rendering active substances soluble and production of therapeutic compositions comprising these substances
HK1081865A1 (en) Popping oral administration form
UA27043C2 (en) Microspherical particles for the parenteral injection of pharmaceutically active agent in its control releasing in organism after injection, method for its producing and suspension based on these microspheres
EP2679584A1 (en) Clathrate complex of cyclodextrin or arabinogalactan with 9-phenyl-sym-octahydroselenoxanthene
FR2698791B1 (en) NEW CUCURBITA SP. EXTRACTS, PROCESS FOR THEIR PREPARATION AND DRUGS AND COSMETICS CONTAINING THEM.
WO2000004894A3 (en) Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
CA2298093A1 (en) An anti-cancer therapy agent of arsenic hexoxide (as4o6) of a natural chemical substance and its pharmaceutical composition
ES8700935A1 (en) Substained release pharmaceutical capsules.
DK658387D0 (en) CLODRONAT-CONTAINING MEDICINAL PRODUCTS AND PROCEDURES FOR PRODUCING THEREOF
BR0009927A (en) Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix
HUT64232A (en) Process for the production of the medical agent by the extraction from tanacetum parthenium and for the production of medical prepartives containing it
GR880100338A (en) Method of potentialization of homeopathic remedies
US2990333A (en) Gelatin capsule with nu-alkyl amide, for aqueous vehicles
Syukri et al. Preperation and characterization of Β-cyclodextrin inclusion complexes oral tablets containing poorly water soluble glimipiride using freeze drying method
PT1263413E (en) METHOD OF PREPARING SOLID SCATTERS
ES2018378A6 (en) Preparation of nitratoalkyl-substituted cyclic ethers.
WO2000030605A3 (en) Method for producing medicaments from plant extracts, in a solid form of administration
IT8920465A0 (en) MEDICINAL PREPARATION OF AN EXTRACT OF NETTLE ROOTS, URTICA KIOVENSIS (ROGOWICZ), ITS USE FOR THE TREATMENT OF TUMORS AND PREPARATION PROCESS.
IT1094899B (en) 4-FENIL-8-AMINO-TETRAIDROISOCHINOLINE, PHARMACEUTICAL PREPARATIONS CONTAINING SUCH SUBSTANCES, PROCESS FOR THE PREPARATION OF THESE PREPARATIONS AND THEIR USE AS PRESSURE ANTIDES
EP0433127A3 (en) Sulfated derivative of galactan extracted from klebsiella, process for its preparation, application as medicines and pharmaceutical compositions containing it